ERK/AKT Inactivation and Apoptosis Induction Associate With Quetiapine-inhibited Cell Survival and Invasion in Hepatocellular Carcinoma Cells

Background/Aim: Quetiapine, an atypical antipsychotic, has been encountered as a potential protective agent to suppress various types of tumor growth. However, the inhibitory mechanism of quetiapine in hepatocellular carcinoma (HCC) still remains unclear. The purpose of present study was to investigate the inhibitory mechanism of quetiapine on cell survival and invasion in HCC. Materials and Methods: Changes of apoptotic signaling, migration/invasion ability, and signaling transduction involved in cell survival and invasion were evaluated with flow cytometry, migration/invasion, and western blot assays. Results: Quetiapine inhibited cell proliferation and migration/invasion in SK-Hep1 and Hep3B cells. Quetiapine induced extrinsic and intrinsic apoptotic pathways. Activation of extracellular signal-regulated kinases (ERK), protein kinase B (AKT), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-ĸB), expression of anti-apoptotic, and metastasis-associated proteins were decreased by quetiapine. Conclusion: The apoptosis induction, the decreased expression of ERK/AKT-mediated anti-apoptotic and the metastasis-associated proteins were associated with quetiapine-inhibited cell survival and invasion in HCC in vitro.

[1]  Fei-Ting Hsu,et al.  Protein Kinase B Inactivation Is Associated with Magnolol-Enhanced Therapeutic Efficacy of Sorafenib in Hepatocellular Carcinoma In Vitro and In Vivo , 2019, Cancers.

[2]  Jing-Gung Chung,et al.  Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[3]  R. McIntyre,et al.  Antipsychotic use is inversely associated with gastric cancer risk: A nationwide population‐based nested case‐control study , 2019, Cancer medicine.

[4]  R. McIntyre,et al.  New use for old drugs: The protective effect of atypical antipsychotics on hepatocellular carcinoma , 2019, International journal of cancer.

[5]  Jing-Gung Chung,et al.  Regorefenib induces extrinsic/intrinsic apoptosis and inhibits MAPK/NF‐κB‐modulated tumor progression in bladder cancer in vitro and in vivo , 2019, Environmental toxicology.

[6]  Fei-Ting Hsu,et al.  Fluoxetine Induces Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits ERK/NF-κB-Modulated Anti-Apoptotic and Invasive Potential in Hepatocellular Carcinoma Cells In Vitro , 2019, International journal of molecular sciences.

[7]  F. Liu,et al.  Antiproliferative activities of the second-generation antipsychotic drug sertindole against breast cancers with a potential application for treatment of breast-to-brain metastases , 2018, Scientific Reports.

[8]  Chung-Jung Liu,et al.  Synergistic antimetastatic effect of cotreatment with licochalcone A and sorafenib on human hepatocellular carcinoma cells through the inactivation of MKK4/JNK and uPA expression , 2018, Environmental toxicology.

[9]  Jing-Gung Chung,et al.  Fluoxetine Inhibits DNA Repair and NF-ĸB-modulated Metastatic Potential in Non-small Cell Lung Cancer , 2018, AntiCancer Research.

[10]  Jie Chen.  The prognostic analysis of different metastatic patterns in advanced liver cancer patients: A population based analysis , 2018, PloS one.

[11]  Juan Du,et al.  Inhibition of cFLIP overcomes acquired resistance to sorafenib via reducing ER stress‑related autophagy in hepatocellular carcinoma. , 2018, Oncology reports.

[12]  T. Ahern,et al.  Use of antipsychotics and risk of breast cancer: a Danish nationwide case–control study , 2018, British journal of clinical pharmacology.

[13]  F. Lu,et al.  β‐mangostin suppresses human hepatocellular carcinoma cell invasion through inhibition of MMP‐2 and MMP‐9 expression and activating the ERK and JNK pathways , 2017, Environmental toxicology.

[14]  Yu-Chang Liu,et al.  Regorafenib diminishes the expression and secretion of angiogenesis and metastasis associated proteins and inhibits cell invasion via NF-κB inactivation in SK-Hep1 cells. , 2017, Oncology letters.

[15]  X. Bian,et al.  Promoting oligodendroglial-oriented differentiation of glioma stem cell: a repurposing of quetiapine for the treatment of malignant glioma , 2017, Oncotarget.

[16]  M. Okada,et al.  Aripiprazole, an Antipsychotic and Partial Dopamine Agonist, Inhibits Cancer Stem Cells and Reverses Chemoresistance. , 2016, Anticancer research.

[17]  Chiun Hsu,et al.  Cyclin E1 Inhibition can Overcome Sorafenib Resistance in Hepatocellular Carcinoma Cells Through Mcl-1 Suppression , 2015, Clinical Cancer Research.

[18]  John Lally,et al.  Antipsychotic medication in schizophrenia: a review. , 2015, British medical bulletin.

[19]  T. Chu,et al.  Quetiapine inhibits osteoclastogenesis and prevents human breast cancer-induced bone loss through suppression of the RANKL-mediated MAPK and NF-κB signaling pathways , 2015, Breast Cancer Research and Treatment.

[20]  Guan-Jhong Huang,et al.  Anti-inflammatory effects of trilinolein from Panax notoginseng through the suppression of NF-κB and MAPK expression and proinflammatory cytokine expression. , 2014, The American journal of Chinese medicine.

[21]  Yan Zhang,et al.  Elevated expression levels of androgen receptors and matrix metalloproteinase-2 and -9 in 30 cases of hepatocellular carcinoma compared with adjacent tissues as predictors of cancer invasion and staging , 2014, Experimental and therapeutic medicine.

[22]  Fei-Ting Hsu,et al.  Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-κB signaling. , 2014, International journal of oncology.

[23]  F. Kaymaz,et al.  Neuroprotective Effects of Quetiapine on Neuronal Apoptosis Following Experimental Transient Focal Cerebral Ischemia in Rats , 2013, Journal of Korean Neurosurgical Society.

[24]  Jai-Sing Yang,et al.  Bufalin increases sensitivity to AKT/mTOR-induced autophagic cell death in SK-HEP-1 human hepatocellular carcinoma cells. , 2012, International journal of oncology.

[25]  Sang-Hyon Kim,et al.  Anti-inflammatory effect of quetiapine on collagen-induced arthritis of mouse. , 2012, European journal of pharmacology.

[26]  I. Fabregat.  Dysregulation of apoptosis in hepatocellular carcinoma cells. , 2009, World journal of gastroenterology.

[27]  J. H. Kim,et al.  Association between increment of serum VEGF level and prognosis after transcatheter arterial chemoembolization in hepatocellular carcinoma patients , 2008, Cancer science.

[28]  H. Möller,et al.  Quetiapine in the treatment of schizophrenia and related disorders , 2007, Neuropsychiatric disease and treatment.

[29]  H.-B. Tang,et al.  Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor , 2000, Journal of Cancer Research and Clinical Oncology.

[30]  K. Shiraki,et al.  Reduced expression of ICE/caspase1 and CPP32/caspase3 in human hepatocellular carcinoma. , 2000, Anticancer research.

[31]  M. Monden,et al.  The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma , 2000, British Journal of Cancer.

[32]  Jing-Gung Chung,et al.  Glycyrrhizic Acid Modulates Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits Protein Kinase B- and Extracellular Signal-Regulated Kinase-Mediated Metastatic Potential in Hepatocellular Carcinoma In Vitro and In Vivo. , 2020, The American journal of Chinese medicine.